Skip to main content
. Author manuscript; available in PMC: 2018 Dec 3.
Published in final edited form as: Intensive Care Med. 2016 Oct 3;42(12):1899–1911. doi: 10.1007/s00134-016-4576-0

Table 3.

Necrotizing fasciitis—pathogens and treatments by anatomical site

Anatomical location Predominant pathogens Empiric antimicrobial therapy
Head/neck Anaerobes Ampicillin/sulbactam usually sufficient, though MRSA coverage should be considered, particularly in immunosuppressed or IV drug abusers
Abdomen/perineal Gram negative, anaerobes Cefepime + metronidazole OR an anti-pseudomonal carbapenem OR piperacillin- tazobactam
Lower extremity Gram negative, anaerobes, Gram positive In MRSA prevalent areas vancomycin PLUS cefepime + metronidazole OR an anti- pseudomonal carbapenem OR piperacillin-tazobactam
Surgical site Variable depending on surgical site In addition to anatomic location pertinent antimicrobials, if not already included, MRSA coverage should be considered in regions with high incidence